🔎 Trials Near Me

Beranda › Limfoma › New Jersey › Edison

Uji klinis Limfoma di Edison, NJ

12 studi untuk Limfoma mencari peserta di lokasi sekitar Edison (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Rutgers University Study of the Genetics of Blood Cancers

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Rutgers University, Piscataway · 2 mi jauhnya
Usia 18 hingga 110 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07714044

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Menerima pesertaFase 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07015242

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

Menerima pesertaFase 2
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT02974647

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

Menerima pesertaFase 1
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT04301076

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

Menerima pesertaFase 3
  • Research Site, Basking Ridge · 15 mi jauhnya
Usia 18 hingga 18 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07509151

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

Menerima pesertaFase 3
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06084936

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Menerima pesertaFase 2
  • Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities, Basking Ridge · 15 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT05389293

A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)

Menerima pesertaFase 1
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Jun 2026 · NCT07137494

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

Menerima pesertaSukarelawan sehat diterima
  • Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge · 15 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Mei 2026 · NCT07052916

A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

Menerima pesertaFase 2
  • Memorial Sloan Kettering at Basking Ridge (All protocol activities), Basking Ridge · 15 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mar 2026 · NCT06698003

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

Menerima pesertaStudi observasional
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauhnya
Usia 18 ke atas · Wanita · Diperbarui 4 Mar 2026 · NCT01788839

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauhnya
Semua usia · Semua jenis kelamin · Diperbarui 23 Jan 2026 · NCT00582621

Uji klinis Limfoma di kota lain

Studi lain di Edison

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.